Advanced Enzyme Technologies Limited (ADVENZYMES) - Net Assets

Latest as of March 2026: Rs16.83 Billion INR ≈ $182.02 Million USD

Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has net assets worth Rs16.83 Billion INR (≈ $182.02 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs18.39 Billion ≈ $198.86 Million USD) and total liabilities (Rs1.56 Billion ≈ $16.83 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Advanced Enzyme Technologies Limited tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs16.83 Billion
% of Total Assets	91.54%
Annual Growth Rate	24.65%
5-Year Change	47.59%
10-Year Change	256.2%
Growth Volatility	18.53

Advanced Enzyme Technologies Limited - Net Assets Trend (2008–2026)

This chart illustrates how Advanced Enzyme Technologies Limited's net assets have evolved over time, based on quarterly financial data. See ADVENZYMES defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Advanced Enzyme Technologies Limited (2008–2026)

The table below shows the annual net assets of Advanced Enzyme Technologies Limited from 2008 to 2026. For live valuation and market cap data, see Advanced Enzyme Technologies Limited market cap and net worth.

Year	Net Assets	Change
2026-03-31	Rs16.83 Billion ≈ $182.02 Million	+14.60%
2025-03-31	Rs14.69 Billion ≈ $158.83 Million	+7.12%
2024-03-31	Rs13.71 Billion ≈ $148.28 Million	+6.77%
2023-03-31	Rs12.84 Billion ≈ $138.88 Million	+12.61%
2022-03-31	Rs11.40 Billion ≈ $123.33 Million	+10.63%
2021-03-31	Rs10.31 Billion ≈ $111.47 Million	+18.83%
2020-03-31	Rs8.67 Billion ≈ $93.81 Million	+23.08%
2019-03-31	Rs7.05 Billion ≈ $76.22 Million	+21.17%
2018-03-31	Rs5.82 Billion ≈ $62.91 Million	+23.10%
2017-03-31	Rs4.73 Billion ≈ $51.10 Million	+66.71%
2016-03-31	Rs2.83 Billion ≈ $30.65 Million	+30.96%
2015-03-31	Rs2.16 Billion ≈ $23.41 Million	+26.53%
2014-03-31	Rs1.71 Billion ≈ $18.50 Million	+3.09%
2013-03-31	Rs1.66 Billion ≈ $17.94 Million	+68.61%
2012-03-31	Rs984.09 Million ≈ $10.64 Million	+52.49%
2011-03-31	Rs645.35 Million ≈ $6.98 Million	+31.90%
2010-03-31	Rs489.29 Million ≈ $5.29 Million	+28.82%
2009-03-31	Rs379.81 Million ≈ $4.11 Million	+18.99%
2008-03-31	Rs319.19 Million ≈ $3.45 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Advanced Enzyme Technologies Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 0.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Common Stock	Rs223.85 Million	1.37%
Other Components	Rs16.10 Billion	98.63%
Total Equity	Rs16.32 Billion	100.00%

Advanced Enzyme Technologies Limited Competitors by Market Cap

The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their market capitalization.

Company	Market Cap
Hangzhou Electn Soul Network SHG:603258	$452.19 Million
Deutsche Pfandbriefbank AG XETRA:PBB	$452.37 Million
QUADIENT SA ADR1/15/EO 1 F:NEQ0	$452.52 Million
King’s Town Construction Co Ltd TW:2524	$452.57 Million
Sandhar Technologies Limited NSE:SANDHAR	$452.14 Million
Qingdao Vland Biotech Co Ltd SHG:603739	$452.09 Million
Sawit Sumbermas Sarana Tbk JK:SSMS	$452.08 Million
Shenzhen Ellassay Fashion Co SHG:603808	$452.06 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Advanced Enzyme Technologies Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 14,208,630,000 to 16,319,570,000, a change of 2,110,940,000 (14.9%).
Net income of 1,687,190,000 contributed positively to equity growth.
Dividend payments of 597,780,000 reduced retained earnings.
New share issuances of 9,530,000 increased equity.
Other comprehensive income decreased equity by 1,613,860,000.
Other factors increased equity by 2,625,860,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs1.69 Billion	+10.34%
Dividends Paid	Rs597.78 Million	-3.66%
Share Issuances	Rs9.53 Million	+0.06%
Other Comprehensive Income	Rs-1.61 Billion	-9.89%
Other Changes	Rs2.63 Billion	+16.09%
Total Change	Rs-	14.86%

Book Value vs Market Value Analysis

This analysis compares Advanced Enzyme Technologies Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.56x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 128.03x to 2.56x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2008-03-31	Rs2.92	Rs373.40	x
2009-03-31	Rs3.45	Rs373.40	x
2010-03-31	Rs4.40	Rs373.40	x
2011-03-31	Rs6.10	Rs373.40	x
2012-03-31	Rs9.34	Rs373.40	x
2013-03-31	Rs15.33	Rs373.40	x
2014-03-31	Rs15.38	Rs373.40	x
2015-03-31	Rs19.47	Rs373.40	x
2016-03-31	Rs25.55	Rs373.40	x
2017-03-31	Rs41.56	Rs373.40	x
2018-03-31	Rs50.07	Rs373.40	x
2019-03-31	Rs60.76	Rs373.40	x
2020-03-31	Rs75.10	Rs373.40	x
2021-03-31	Rs86.77	Rs373.40	x
2022-03-31	Rs97.31	Rs373.40	x
2023-03-31	Rs110.46	Rs373.40	x
2024-03-31	Rs118.35	Rs373.40	x
2025-03-31	Rs126.81	Rs373.40	x
2026-03-31	Rs145.67	Rs373.40	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Advanced Enzyme Technologies Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 10.34%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 22.62%
• Asset Turnover: 0.41x
• Equity Multiplier: 1.13x
Recent ROE (10.34%) is below the historical average (18.17%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	15.95%	8.28%	0.67x	2.86x	Rs18.88 Million
2009	18.68%	8.33%	0.90x	2.51x	Rs32.57 Million
2010	23.97%	10.11%	1.04x	2.28x	Rs66.84 Million
2011	26.35%	14.36%	0.75x	2.43x	Rs103.44 Million
2012	34.86%	19.71%	0.49x	3.61x	Rs240.72 Million
2013	30.49%	22.70%	0.55x	2.42x	Rs334.81 Million
2014	11.79%	9.20%	0.53x	2.43x	Rs29.94 Million
2015	24.05%	22.95%	0.53x	1.96x	Rs297.82 Million
2016	27.28%	25.92%	0.65x	1.62x	Rs480.40 Million
2017	19.70%	27.46%	0.57x	1.25x	Rs446.33 Million
2018	16.11%	23.22%	0.53x	1.31x	Rs341.47 Million
2019	16.36%	26.59%	0.52x	1.19x	Rs431.75 Million
2020	15.40%	29.28%	0.45x	1.17x	Rs453.29 Million
2021	15.03%	29.16%	0.43x	1.19x	Rs488.65 Million
2022	10.99%	22.61%	0.42x	1.16x	Rs107.23 Million
2023	8.55%	19.54%	0.38x	1.15x	Rs-178.68 Million
2024	10.07%	21.38%	0.41x	1.16x	Rs8.92 Million
2025	9.23%	20.59%	0.39x	1.14x	Rs-109.71 Million
2026	10.34%	22.62%	0.41x	1.13x	Rs55.23 Million

Industry Comparison

This section compares Advanced Enzyme Technologies Limited's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

Industry: Specialty Chemicals
Average net assets among peers: $3,942,068,711
Average return on equity (ROE) among peers: 15.07%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Advanced Enzyme Technologies Limited (ADVENZYMES)	Rs16.83 Billion	15.95%	0.09x	$452.18 Million
Aarti Industries Limited (AARTIIND)	$3.75 Billion	25.25%	1.91x	$1.91 Billion
Aarti Surfactants Limited (AARTISURF)	$1.36 Billion	4.04%	1.96x	$35.50 Million
ABM International Limited (ABMINTLLTD)	$148.54 Million	-22.96%	1.64x	$4.23 Million
Aether Industries Limited (AETHER)	$3.87 Billion	28.16%	0.99x	$1.66 Billion
Akzo Nobel India Limited (AKZOINDIA)	$8.48 Billion	17.72%	1.40x	$1.60 Billion
Alkali Metals Limited (ALKALI)	$293.96 Million	25.87%	0.91x	$9.63 Million
Alkyl Amines Chemicals Limited (ALKYLAMINE)	$11.69 Billion	19.56%	0.36x	$990.72 Million
Ami Organics Limited (AMIORG)	$822.19 Million	28.33%	1.59x	$1.18 Billion
Anupam Rasayan India Limited (ANURAS)	$5.07 Billion	9.71%	1.61x	$1.58 Billion

About Advanced Enzyme Technologies Limited

NSE:ADVENZYMES India Specialty Chemicals

Market Cap

$452.18 Million

Rs41.81 Billion INR

Market Cap Rank

#12958 Global

#631 in India

Share Price

Rs373.40

Change (1 day)

+0.16%

52-Week Range

Rs255.30 - Rs392.10

All Time High

Rs549.90